Task: Answer the multiple-choice question.
Question: Which drug has a 4.486% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C)C[C@H]1COCCS(=O)(=O)N1Cc1cccc(F)c1
b CS(=O)(=O)c1ccc(Cl)c(NC(=O)COC(=O)CNC(=O)c2ccc3ccccc3c2)c1
c COc1ccc(CNC(=O)C2CC(c3ccc(C(F)(F)F)cc3)=NO2)cc1
Answer: a. CC(C)C[C@H]1COCCS(=O)(=O)N1Cc1cccc(F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C[C@H]1COCCS(=O)(=O)N1Cc1cccc(F)c1
CC(C)C[C@H]1COCCS(=O)(=O)N1Cc1cccc(F)c1
(6S)-5-[(3-fluorophenyl)methyl]-6-(2-methylpropyl)-1,4,5-oxathiazepane 4,4-dioxide